Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical Histopathological Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199305 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Veronica Iturriaga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integral Adult Care Dentistry, Temporomandibular Disorder and Orofacial Pain Program, Universidad de La Frontera, Temuco 4811230, Chile. Hauptthemen laut MEDLINE: Osteoarthritis, Proteoglycans, Recombinant Proteins, Temporomandibular Joint. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de La Frontera, Project DI20-0018, Temporomandibular Disorder and Orofacial Pain Program, Universidad de La Frontera, Chile.
Abstract (Originalsprache)
The proposed research aims to evaluate the histopathological effects of the intra-articular administration of recombinant human proteoglycan 4 (rhPRG4) on an experimental model of induced temporomandibular joint (TMJ) osteoarthritis (OA) in rabbits. An experimental study was conducted on rabbit TMJs. Twenty-four TMJs were included, distributed as follows: (1) TMJ-C, a control group consisting of four healthy TMJs; (2) TMJ-OA, a group consisting of five TMJs with OA; (3) TMJ-OA-WT, a group consisting of five untreated TMJ-OAs; (4) rhPRG4-30, a group consisting of five TMJ-OAs treated with rhPRG4 30 μg/mL; and (5) rhPRG4-100, a group consisting of five TMJ-OAs treated with rhPRG4 100 μg/mL. A histopathological analysis was performed, considering the mandibular condyle, articular disc, and mandibular fossa, comparing the groups. In addition, a quantitative comparative analysis was performed using the Osteoarthritis Research Society International (OARSI) scale. Kruskal–Wallis and Dunn’s post hoc tests were used for statistical analysis, considering a statistical significance of p < 0.05. The histological analysis of TMJ tissue reveals key differences between healthy, osteoarthritic, and rhPRG4-treated joints. The intra-articular infiltration of rhPRG4 in TMJ-OA has a cartilage and articular disc repair effect, reducing the severity of osteoarthritis and promoting a more organized cartilage structure, with slightly better results at the 30 μg/mL concentration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integral Adult Care Dentistry, Temporomandibular Disorder and Orofacial Pain Program, Universidad de La Frontera, Temuco 4811230, Chile.
- Sleep & Pain Research Group, Universidad de La Frontera, Temuco 4811230, Chile.
- Center of Excellence in Morphological and Surgical Studies, Universidad de La Frontera, Temuco 4811230, Chile.
- Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4811230, Chile.
- Grupo de Investigación de Pregrado en Odontología, Facultad de Ciencias de la Salud (FACSA), Universidad Autónoma de Chile, Temuco 4810101, Chile.
- Doctoral Program in Morphological Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4811230, Chile.
ORCID-Profile: Veronica Iturriaga, Bélgica Vásquez, Mariano Del Sol
Förderung
- Universidad de La Frontera
- Project DI20-0018
- Temporomandibular Disorder and Orofacial Pain Program, Universidad de La Frontera, Chile
Zitieren
APA
Iturriaga, V., Vásquez, B., Wen, S., Bornhardt, T., Navarrete, J., & Del Sol, M. (2025). Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical Histopathological Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199305
Vancouver
Iturriaga V, Vásquez B, Wen S, Bornhardt T, Navarrete J, Del Sol M. Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical Histopathological Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199305
BibTeX
@article{Iturriaga2025,
author = {Iturriaga, Veronica and Vásquez, Bélgica and Wen, Schilin and Bornhardt, Thomas and Navarrete, Javiera and Del Sol, Mariano},
title = {Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical Histopathological Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199305}
}
EUVIMED